ReviewJournal of the Chinese Medical Association : JCMA2020
Cardiovascular manifestation and treatment in COVID-19.
Review in Journal of the Chinese Medical Association : JCMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 38 citations in OpenAlex.
- Pathogenic mechanisms of cardiovascular damage in COVID-19.Molecular medicine (Cambridge, Mass.) · 2024Review
- The molecular mechanism of cardiac injury in SARS-CoV-2 infection: Focus on mitochondrial dysfunction.Journal of infection and public health · 2023Article
- Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner.BMC infectious diseases · 2023Article
- Pericardial Involvement in Severe COVID-19 Patients.Medicina (Kaunas, Lithuania) · 2022Observational
- Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination.Vaccines · 2022Article
- Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications.Inflammopharmacology · 2022Review
- The Influence of SARS-CoV-2 Pandemic on TMJ Disorders, OSAS and BMI.International journal of environmental research and public health · 2022Article
- The Role of NLRP3 Inflammasome Activation and Oxidative Stress in Varicocele-Mediated Male Hypofertility.International journal of molecular sciences · 2022Review
- Article
- Effusive-constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report.European heart journal. Case reports · 2022Article
- Acute Pericarditis Secondary to COVID-19 Infection.Cureus · 2021Article
- Coronavirus Disease 2019.Clinics in geriatric medicine · 2021Review
- Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre.Global cardiology science & practice · 2021Review
- Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes.Best practice & research. Clinical anaesthesiology · 2021Review
- The perception of COVID-19 among Italian dental patients: an orthodontic point of view.Progress in orthodontics · 2021Article
- Impact of screening COVID-19 on orthopedic trauma patients at the emergency department: A consecutive series from a level I trauma center.Journal of the Chinese Medical Association : JCMA · 2021Observational
- An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19.Current research in pharmacology and drug discovery · 2021Review
- COVID-19 Severity: Lung-Heart Interplay.Current cardiology reviews · 2021Review
- Article
- The Perception of COVID-19 among Italian Dentists: An Orthodontic Point of View.International journal of environmental research and public health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 countries, caused 2 310 572 infected individuals and 158 691 mortalities, updated on April 19, 2020. Many studies have published timely to help global healthcare workers to understand and control the disease. Vulnerable patients with risk factors such as elderly, cardiovascular diseases (eg, hypertension, coronary disease, or cardiomyopathy), diabetes, and chronic kidney disease have worse outcomes after COVID-19 infection. COVID-19 could directly cause cardiovascular injuries such as pericarditis, myocarditis, myocardial infarction, heart failure, arrhythmias, or thromboembolic events, which urge cardiologists to be involved in the frontline to practice. Here, we provide a review of COVID-19 on cardiovascular system to assist clinical cardiologists to better understand the disease and being capable of providing comprehensive medical support.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.